NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ESOP Holders Face Uncertain Future Amid Delayed IPOs

The ongoing conflict in West Asia has cast a shadow over the Indian market, with foreign investors pulling out and the economic outlook looking increasingly challenging. This has had a direct impact on listing plans, with initial public offerings (IPOs) becoming uncertain for many companies that are either directly or indirectly affected by the conflict. As a result, the IPO timelines of several companies have been delayed, causing concern for a section of employees who exercised their employee stock ownership plans (ESOPs) using leverage, expecting a near-term liquidity event.

Vulnerable ESOP Holders

According to wealth managers, most employees do not prefer to exercise their ESOPs using leverage and usually wait for a liquidity event like an IPO before exercising the stock options. However, certain segments of ESOP holders, especially ex-employees, could find themselves vulnerable as they have a limited timeframe to exercise their ESOPs after quitting (usually 30-90 days), or risk losing those stock options.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

ESOP Holder SegmentLoan Tenure (months)Interest RatePotential Loss
Ex-employees with leverage24-3611%20-33%
Employees with current investments---

Wealth managers say the problem arises when both the employee and the lender assume a near-term IPO while structuring ESOP financing. This can lead to financial stress for ESOP holders when the IPO timeline slips beyond their loan tenure.

India's Taxation Structure Adds to the Burden

When ESOPs are exercised, the employee pays a perquisite tax at their slab rate on the gap between strike price and fair market value. That tax is paid in cash, today, on a gain that exists only on paper. ESOP financing in India commonly carries interest rates of around 11 percent with tenures of 24-36 months. If the eventual IPO valuation is lower than expected, the perquisite tax does not refund itself, and the leveraged exerciser can genuinely end up worse off than the colleague who simply waited.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Wealth Managers' Advice

Wealth managers argue against aggressive ESOP exercise strategies funded through leverage. They caution against refinancing such ESOP-linked loans, as one is extending the cost of a bet whose timeline they do not control, and adding interest on interest to a position that is already stretched. Secondary sales are the only strategy worth taking seriously, but these transactions come with their own frictions, including the need for company approval and a widening discount on the value of the shares in a soft market.

Refinancing ESOP-Linked Loans: A High-Risk Strategy

Refinancing ESOP-linked loans can lead to a cycle of debt, where the interest on the loan adds to the original cost, making it even more difficult for ESOP holders to recover their investment. Wealth managers advise against this strategy, as it can lead to a significant loss for ESOP holders.

Secondary Sales: A Viable Option

Secondary sales offer a viable option for ESOP holders who are stuck with leverage and no exit visibility. However, these transactions come with their own frictions, including the need for company approval and a widening discount on the value of the shares in a soft market. Wealth managers advise ESOP holders to carefully consider their options before making a decision.

Investor Takeaway

Investors should be cautious of potential delays in IPOs and their impact on leveraged ESOP participants.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.